Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults

References

• Chacko A, Newcorn JH, Feirsen N, Uderman JZ. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr. Pharm. Des. 16(22), 2416–2423 (2010).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to Long Term Therapies: a Call to Action. World Health Organization, Geneva, Switzerland (2003).
   Google Scholar
• Clay D, Farris K, Mccarthy AM, Kelly MW, Howarth R. Family perceptions of medication administration at school: errors, risk factors, and consequences. J. Sch. Nurs. 24(2), 95–102 (2008).
   PubMed Web of Science ®Google Scholar
• Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv. Ther. 22(4), 313–356 (2005).
   PubMed Web of Science ®Google Scholar
• Farris KB, McCarthy AM, Kelly MW, Clay DL, Gross JL. Issues of medication administration and control in Iowa schools. J. Sch. Health 73(9), 331–37 (2003).
   PubMed Web of Science ®Google Scholar
• Rapoff MA. Adherence to Pediatric Medical Regimens. Plenum Publishers, New York, USA (1999).
   Google Scholar
• Buckley P. Adherence to Mental Health Treatment. Oxford University Press, New York, USA (2009).
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med. 353(5), 487–497 (2005).
   PubMed Web of Science ®Google Scholar
• Fredericks EM, Magee JC, Opipari-Arrigan L, Shieck V, Well A, Lopez MJ. Adherence and health-related quality of life in adolescent liver transplant recipients. Pediatr. Transplant. 12(3), 289–299 (2008).
   Google Scholar
• Drotar D, Greenley RN, Demeter CA et al. Adherence to pharmacological treatment for juvenile bipolar disorder. J. Am. Acad. Child Adol. Psychiatry 46(7), 831–839 (2007).
   Google Scholar
• Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J. Pediatr. Psychol. 33(8), 867–874 (2008).
   PubMed Web of Science ®Google Scholar
• Ekberg H, Kyllonen L, Madsen S, Grave G, Solbu D, Holdaas H. Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists. Transplantation 84(8), 1052–1054 (2007).
   Google Scholar
• Lehane E, Mccarthy G. Medication non-adherence-exploring the conceptual mire. Int. J. Nurs. Practice 15(1), 25–31 (2009).
   Google Scholar
• Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch. Intern. Med. 153(16), 1863–1868 (1993).
   PubMed Web of Science ®Google Scholar
• The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N. Engl. J. Med. 303(18), 1038–1041 (1980).
   Google Scholar
• National Council on Patient Information and Education. Enhancing Prescription Medicine Adherence. A National Action Plan. National Council on Patient Information and Education, Rockville, MD, USA (2007).
   Google Scholar
• World Health Organization. Global Status Report on Non-Communicable Diseases 2010. World Health Organization, Geneva, Switzerland (2010).
   Google Scholar
• Matsui D. Current issues in pediatric medication adherence. Pediatr. Drugs 9(5), 283–288 (2007).
   PubMedGoogle Scholar
• La Greca AM. Issues in adherence with pediatric regimens. J. Pediatr. Psychol. 15(4), 423–436 (1990).
   Google Scholar
• Winnick S, Lucas DO, Hartman AL, Toll D. How do you improve compliance? Pediatrics 115(6), e718–e724 (2005).
   PubMed Web of Science ®Google Scholar
• Hummelinck A, Pollock K. Parents’ information needs about the treatment of their chronically ill child: a qualitative study. Patient Educ. Couns. 62, 228–234 (2005).
   Google Scholar
• Charach A. ADHD treatment: Strategies for optimizing adherence. Consultant 51(11), 824–833 (2011).
   Google Scholar
• Bokhari FAS, Heiland F, Levine P, Ray GT. Risk factors for discontinuing drug therapy among children with ADHD. Health Serv. Outcomes Res. Methodol. 8(3), 134–158 (2008).
   Google Scholar
• Khoza S, Oladapo AO, Barner JC. Adherence to medication for attention deficit/hyperactivity disorder: Does time frame matter? J. Pharm. Health Serv. Res. 2(3), 157–163 (2011).
   Google Scholar
• Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J. Clin. Psychiatry 65, 1301–1313 (2004).
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Wibbelsman CJ, Brown TE et al. Attention deficit/hyperactivity disorder among adolescents: a review of diagnosis, treatment, and clinical implications. Pediatrics 115, 1734–1746 (2005).
   PubMed Web of Science ®Google Scholar
• Summers JA, Caplan PJ. Laypeople’s attitudes toward drug treatment for behavioural control depend on which disorder and which drug. Clin. Pediatr. 26, 258–263 (1987).
   PubMed Web of Science ®Google Scholar
• Wilcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurother. 9, 490–499 (2012).
   PubMed Web of Science ®Google Scholar
• Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Brit. J. Psychiat. 194, 204–211 (2009).
   PubMed Web of Science ®Google Scholar
• Lien MT, Carlson JS, Hunter-Oehmke S, Knapp KA. A pilot investigation of teachers’ perceptions of psychotropic drug use in schools. J. Atten. Disord. 11, 172–178 (2007).
   Google Scholar
• Culpepper L. Primary care treatment of attention-deficit/hyperactivity disorder. J. Clin. Psychiat. 67( Suppl. 8), 51–58 (2006).
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. Clinical Practice Points on the diagnosis, assessment and management of attention deficit hyperactivity disorder in children and adolescents. NHMRC Publications, Canberra, Commonwealth of Australia (2012).
   Google Scholar
• Wolraich M, Brown L, Brown RT et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128(5), 1007–1022 (2011).
   PubMed Web of Science ®Google Scholar
• Knutson KC, O’Malley M. Adult attention-deficit/hyperactivity disorder: A survey of diagnosis and treatment practices. J. Am. Acad. Nurse Pract. 22, 593–601 (2009).
   Google Scholar
• Murray DW. Treatment of preschoolers with attention-deficit/hyperactivity disorder. Curr. Psychiatry Rep. 12, 374–381 (2010).
   PubMed Web of Science ®Google Scholar
• Jadad AR, Booker L, Gauld M et al. The treatment of attention-deficit hyperactivity disorder: An annotated bibliography and critical appraisal of published systematic reviews and meta-analyses. Can. J. Psychiat. 44(10), 1025–1035 (1999).
   Web of Science ®Google Scholar
• Kaplan G, Newcorn JH. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. Pediatr. Clin. North Am. 58, 99–120 (2011).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. Med. Gen. Med. 8(4), 4 (2006).
   PubMedGoogle Scholar
• Pliszka SR, Crimson ML, Hughes CW et al. Texas Consensus Conference Panel on pharmacotherapy of childhood attention deficit hyperactivity disorder. Revision of the algorithm for pharmacotherapy of attention deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 45, 642–657 (2006).
   PubMed Web of Science ®Google Scholar
• Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit hyperactivity disorder. N. Engl. J. Med. 340, 780–788 (1999).
   PubMed Web of Science ®Google Scholar
• Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 7, 849–921 (2007).
   Google Scholar
• Dopheide JA. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD. Am. J. Manag. Care 15(5 Suppl.), S141–S150 (2009).
   Google Scholar
• Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 29(6), 656–679 (2009).
   PubMed Web of Science ®Google Scholar
• Merkel RL, Kuchibhalta A. Safety of stimulant treatment in attention deficit hyperactivity disorder: part I. Expert Opin. Drug Saf. 8, 655–668, (2009).
   PubMed Web of Science ®Google Scholar
• Merkel RL. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II. Expert Opin. Drug Saf. 9, 917–935, (2010).
   PubMed Web of Science ®Google Scholar
• Ferrin M, Ruiz-Veguilla M, Blanc-Betes M et al. Evaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD). Eur. Child Adolesc. Psychiatry 21(7), 387–401 (2012).
   PubMed Web of Science ®Google Scholar
• Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch. Pediatr. Adolesc. Med. 159(6), 572–578 (2005).
   PubMedGoogle Scholar
• Charach A, Volpe T, Boydell KM, Gearing RE. A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv. Rev. Psychiatry 16(2), 126–135 (2008).
   PubMed Web of Science ®Google Scholar
• Safren SA, Duran P, Yovel I, Perlman CA, Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J. Atten. Disord. 10(3), 257–260 (2007).
   PubMedGoogle Scholar
• Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad. Med. 122(1), 184–191 (2010).
   PubMed Web of Science ®Google Scholar
• Woodruff TJ, Axelrad DA, Kyle AD, Nweke O, Miller GG, Hurley BJ. Trends in environmentally related childhood illnesses. Pediatrics, 113(4 Suppl.), 1133–1140 (2004).
   PubMed Web of Science ®Google Scholar
• Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: National estimates from the Medical Expenditure Panel Survey. Arch. Pediatr. Adolesc. Med. 156, 504–511 (2002).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A et al. Medication compliance and persistence: terminology and definitions. Value Health 11(1), 44–47 (2008).
   PubMed Web of Science ®Google Scholar
• Vlasnik JJ, Aliotta SL, Delor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case. Manager 16(2), 47–51 (2005).
   Google Scholar
• Caisley H, Muller U. Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic review. Eur. Psychiatry 27(5), 343–349 (2012).
   PubMedGoogle Scholar
• Horne R, Weinman J, Barber N et al. Concordance, Adherence and Compliance in Medicine Taking. National Coordinating Centre for NHS Service Delivery and Organisation, London, UK (2006).
   Google Scholar
• Rudd P, Byyny RL, Zachary V et al. Pill count measures of compliance in a drug trial: variability and suitability. Am. J. Hypertens. 1, 309–312 (1988).
   PubMed Web of Science ®Google Scholar
• Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin. Pharmacol. Ther. 46, 163–168 (1989).
   PubMed Web of Science ®Google Scholar
• Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 261, 3273–3277 (1989).
   PubMed Web of Science ®Google Scholar
• Knafl GJ, Schoenthaler A, Ogedegbe G. Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans. Patient Prefer. Adherence 6, 207–219 (2012).
   Web of Science ®Google Scholar
• Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records. Methods, validity, and applications. J. Clin. Epidemiol. 50, 105–116 (1997).
   PubMed Web of Science ®Google Scholar
• Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J. Am. Soc. Hypertens. 6(3), 201–209 (2012).
   PubMed Web of Science ®Google Scholar
• Gau SS-F, Chen S-J, Chou W-J et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J. Clin. Psychiatry 69(1), 131–140 (2008).
   PubMed Web of Science ®Google Scholar
• Chou W-J, Chou M-C, Tzang R-F et al. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry Clin. Neurosci. 63(2), 167–175 (2009).
   PubMed Web of Science ®Google Scholar
• Tzang RF, Wang YC, Yeh CB et al. Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorder. Psychiatry Clin. Neurosci. 66(1), 53–63 (2012).
   Google Scholar
• Rothenberger A, Becker A, Breuer D, Dopfner M. An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur. Child Adolesc. Psychiatry 20( Suppl. 2), S257–S265 (2011).
   Google Scholar
• Atzori P, Usala T, Carucci S, Danjou F, Zuddas A. Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study. J. Child Adolesc. Psychopharmacol. 19(6), 673–681 (2009).
   Google Scholar
• Yang J, Yoon BM, Lee MS, Joe SH, Jung IK, Kim SH. Adherence with electronic monitoring and symptoms in children with attention deficit hyperactivity disorder. Psychiatry Investig. 9(3), 263–268 (2012).
   Google Scholar
• Adler LA, Lynch LR, Shaw DM et al. Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study. Postgrad. Med. 123(5), 71–79 (2011).
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Bosch R, Castells X et al. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 22(7), 603–611 (2008).
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Mick E, Surman CBH et al. A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. J. Atten. Disord. 15(4), 286–294 (2011).
   PubMed Web of Science ®Google Scholar
• Pappadopulos E, Jensen PS, Chait AR et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J. Am. Acad. Child Adolesc. Psychiatry 48(5), 501–510 (2009).
   PubMed Web of Science ®Google Scholar
• Winterstein AG, Gerhard T, Shuster J et al. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann. Pharmacother. 42(1), 24–31 (2008).
   PubMedGoogle Scholar
• Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J. Am. Acad. Child Adolesc. Psychiatry 48(1), 51–59 (2009).
   PubMedGoogle Scholar
• Wong ICK, Asherson P, Bilbow A et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)-a pharmacoepidemiological and qualitative study. Health Technol. Assess. 13(50), iii–iv, ix–xi, 1–120 (2009).
   Web of Science ®Google Scholar
• McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong ICK. Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry 12, 219 (2012).
   PubMed Web of Science ®Google Scholar
• Palli SR, Kamble PS, Chen H, Aparasu RR. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 22(2), 139–148 (2012).
   PubMed Web of Science ®Google Scholar
• Christensen L, Sasane R, Hodgkins P, Harley C, Tetali S. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr. Med. Res. Opin. 26(4), 977–989 (2010).
   PubMed Web of Science ®Google Scholar
• Lachaine J, Beauchemin C, Sasane R, Hodgkins PS. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Postgrad. Med. 124(3), 139–148 (2012).
   PubMed Web of Science ®Google Scholar
• Hodgkins P, Sasane R, Christensen L, Harley C, Liu F. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr. Med. Res. Opin. 27( Suppl. 2), 53–62 (2011).
   PubMed Web of Science ®Google Scholar
• Lawson KA, Johnsrud M, Hodgkins P, Sasane R, Crismon ML. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin. Ther. 34(4), 944–956 e944 (2012).
   PubMed Web of Science ®Google Scholar
• Charach A, Gajaria A. Improving psychostimulant adherence in children with ADHD. Expert Rev. 8(10), 1563–1571 (2008).
   Google Scholar
• Johnston C, Hommersen P, Seipp C. Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics. Behav. Ther. 39, 22–32, (2008).
   PubMed Web of Science ®Google Scholar
• Peters K, Jackson D. Mothers’ experiences of parenting a child with attention deficit hyperactivity disorder. J. Adv. Nurs. 65, 62–71, (2009).
   PubMed Web of Science ®Google Scholar
• Ahmed R, McCaffery KJ, Aslani P. Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 23(3), 163–178 (2013).
   Google Scholar
• Frances A. The first draft of DSM-V. BMJ 340, c1168 (2010).
   PubMed Web of Science ®Google Scholar
• Morrow RL, Garland J, Wright JM, Maclure M, Taylor S, Dormuth CR. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Can. Med. Assoc. J. 184, 755–762 (2012).
   PubMed Web of Science ®Google Scholar
• Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 344, e3502 (2012).
   PubMed Web of Science ®Google Scholar